Pfizer’s ‘edible treatment’ likely to be approved first… introduced next month


The U.S. has urgently approved Pfizer’s pill form for a treatment for coronavirus. The Korean government has also entered into a review to allow an edible corona treatment, and it is expected that we will be able to see Pfizer pills first in the middle of next month at the earliest.

This is the first news reporter Kim Deok-hyun.

Last month, the government pre-purchased edible corona treatment supplies for 404,000 people.

As a result of the coverage, it was confirmed as a result of the coverage that Merck’s LaGebrio supplies were secured for 264,000 people and Pfizer’s Pax Lovid was secured for 140,000 people.

The Ministry of Food and Drug Safety began reviewing emergency use approval for Pax Lovid following Lagevrio.

After reviewing relevant data such as effects and side effects, the final approval is decided through expert advisory meetings, etc.

Paxrovid is expected to complete the approval process within the year.

However, the approval of La Gabrio may pass early next year.

As Merck downgraded the severe preventive effect of Lagebrio from 50% to 30%, it is clear that further review of effectiveness is needed.

This is the explanation of the quarantine authorities.

The government is setting the introduction date for early next year, but depending on the outcome of the negotiations, it could be around mid-January at the earliest.

The government has announced that it will take full advantage of the benefits of oral medicines.

[김옥수/중앙방역대책본부 자원지원팀장 : 주사제가 아니어서 재택환자들에게 매우 유용한 수단이 될 것으로 판단하고 있고 고위험·경증·중등증 환자를 치료하는 병원에서 사용될 것으로….]

The government is also pursuing a plan to purchase more edible medicines.

However, as we saw with the vaccine, the initial quantity is limited and thorough preparation is necessary as countries around the world are competing to purchase ahead of time.

Leave a Reply

Your email address will not be published. Required fields are marked *